CorpDev.Org
Daily News for Dealmakers
Big Deal
TikTok Completes US Joint Venture: Trump Hails Deal as Oracle, Silver Lake Take Control
TikTok has finalized a majority American-owned joint venture to operate its US business, resolving a six-year legal battle over national security concerns and averting a potential ban. The newly formed TikTok USDS Joint Venture LLC will serve over...
Netflix Dismisses Paramount’s Warner Bid as Bidding War Escalates
```html Netflix has publicly rejected Paramount Skydance's counter-offer for Warner Bros. Discovery, calling it inferior on financial and strategic grounds as the two streaming giants intensify their competing acquisition bids. The escalating...
EQT to Acquire Coller Capital for Up to $3.7 Billion in Strategic Push into Private Equity Secondaries
EQT AB, the Swedish private equity giant, has agreed to acquire U.K.-based Coller Capital for a base price of $3.2 billion, with up to $500 million in additional cash contingent on performance milestones. The deal, funded primarily through newly...
Berkshire Hathaway Signals Potential Exit From Kraft Heinz After Decade of Underperformance
```html Warren Buffett's Berkshire Hathaway filed a regulatory notice indicating it may divest its entire 27.5% stake in Kraft Heinz, comprising approximately 325 million shares, marking a dramatic reversal from its 2015 investment in the food...
Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy
```html Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', 'Helvetica Neue', sans-serif; line-height: 1.6; color: #333; background-color: #fff; margin:...
Explainers
Private Equity
International
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Mubadala Exits Arcadia Consumer Healthcare as Bansk Group Assumes Full Control in Continuation Vehicle
Mubadala Capital has sold its minority stake in Arcadia Consumer Healthcare to funds managed by Bansk Group, marking the end of a four-year partnership that tripled the platform's revenue and sharpened its profitability. The transaction, structured...
Revolution Medicines Stock Plunges 20% as Merck Ends $28-32 Billion Acquisition Talks Over Valuation Rift
Merck & Co. has terminated acquisition discussions with Revolution Medicines after failing to agree on price for a potential $28-32 billion deal, triggering a 20% drop in Revolution's shares and exposing tensions in **biotech M&A valuation** amid...
BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema
BioCryst Pharmaceuticals Inc. (NasdaqGS: BCRX) completed its acquisition of Astria Therapeutics Inc. (NasdaqGM: ATXS) from a group of shareholders on January 23, 2026, in a deal valued at $700 million. The transaction bolsters BioCryst's...
Clorox Acquires GOJO Industries for $2.25 Billion, Doubling Down on Health and Hygiene
The Clorox Company has agreed to acquire GOJO Industries, the Ohio-based manufacturer of Purell hand sanitizer and skin health products, in an all-cash transaction valued at $2.25 billion. The deal represents a significant strategic expansion for...
Health Tech SPAC Execs Settle Investor Claims for $10 Million After Bankruptcy Fallout
Former executives of a health technology company that went public through a SPAC merger have agreed to a $10 million settlement to resolve investor lawsuits alleging they triggered a bankruptcy filing that erased shareholder value after product...
